Clinical Trials · NCT04083820
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 521
- Start date
- Sep 2019
- Locations
- 53 sites, France
- Primary endpoint
- Change in Glycated Haemoglobin A1c (HbA1c)